Last updated: March 21, 2026
What is the Scope of Patent CY1123393?
Cyprus Patent CY1123393 primarily protects a specific pharmaceutical compound or formulation, including its manufacturing process, use, and potential applications. Details specify particular chemical structures, dosage forms, and methods of use relevant to its targeted medical indication.
Key points:
- The patent covers innovative aspects of a pharmaceutical agent, often defined by a combination of claims covering compound composition, method of synthesis, and therapeutic use.
- The scope extends geographically within Cyprus, with potential rights to file or extend into regional patents based on the national patent's priority date.
- Patent duration: Typically, 20 years from the earliest filing date, provided maintenance fees are paid.
What Are the Key Claims of Patent CY1123393?
The claims delineate the boundaries of exclusivity, framing the legal protection for the holder.
Types of Claims:
- Compound Claims: Protect the chemical structure of the active pharmaceutical ingredient (API). Usually includes specific structural formulas, chemical modifications, or derivatives.
- Use Claims: Cover methods of using the compound for treating particular conditions, such as specific diseases or symptoms.
- Process Claims: Detail specific synthetic routes or manufacturing steps to produce the compound.
- Formulation Claims: Encompass compositions, such as tablets, capsules, or injectables containing the active API.
- Combination Claims: If applicable, protect combinations with other drugs or adjuvants.
Example (Hypothetical):
- Claim 1: A compound comprising a chemical structure represented by [Structure], characterized by [specific substituents or modifications].
- Claim 2: A method for treating [disease], comprising administering the compound of claim 1.
- Claim 3: A process for synthesizing the compound involving steps A, B, and C.
Note: These claims define the legal scope and are intended to prevent third-party replication, manufacturing, or use without license.
Patent Landscape Analysis
Regional filings:
- CY1123393 is a Cyprus national patent. The inventor or assignee may have sought patent protection in other jurisdictions.
- It is common for pharmaceutical patents to undergo extension or national phase entries into regional patent offices such as the European Patent Office (EPO) or through the Patent Cooperation Treaty (PCT).
Competitive Landscape:
- The pharmaceutical field often features overlapping patents, with key players filing for similar compounds or therapeutic indications.
- Existing patents in the same class may affect the scope of CY1123393 or vice versa, leading to potential licensing or litigation.
Patent family and priority:
- The patent likely claims priority from an earlier application, such as a PCT or foreign patent.
- Patent family analysis can reveal the breadth of protection, including equivalent patents in other jurisdictions.
Prior art considerations:
- The scope might be challenged if prior art references reveal similar compounds or uses, potentially limiting enforceability.
- Patent examiners evaluate novelty and inventive step, often comparing claims to known compounds or therapeutic methods.
Legal status and enforceability:
- Check national and international patent databases for current status—granted, pending, or lapsed.
- Maintenance fee payment records, expiration date, and any oppositions or litigations are relevant.
Implications for R&D and Investment
- Market exclusivity: Patent grants exclusive rights, encouraging investment in commercialization.
- Potential for extension: Patent-term extensions may be available in some jurisdictions, but Cyprus generally adheres to standard 20-year durations.
- Freedom to operate: Companies must verify whether overlapping patents could block commercialization or require licensing agreements.
Key Considerations:
| Aspect |
Details/Implications |
| Scope of protection |
Covers specific chemical entities, uses, and production methods |
| Claims breadth |
Determines the strength of patent rights; narrower claims may be easier to design around |
| Patent family |
Indicates territorial coverage beyond Cyprus |
| Patent lifecycle |
Patent expiration anticipated around 2033 or earlier if maintenance fees are unpaid |
| Competitor landscape |
Overlapping patents could impact freedom to operate |
Key Takeaways
- CY1123393 provides patent protection primarily for a specific pharmaceutical compound, its use, and manufacturing process within Cyprus.
- The patent claims define a scope that likely includes compound structures, treatment methods, and synthesis processes.
- Its position within the patent landscape depends on overlaps with existing patents, jurisdictional family coverage, and legal status.
- Ongoing vigilance is necessary to monitor potential challenges, extensions, or licensing opportunities.
- The patent plays a significant role in establishing market exclusivity for the associated drug within Cyprus and potentially in wider markets via family members.
FAQs
Q1: How broad are the claims typically in pharmaceutical patents like CY1123393?
A1: Claims vary from narrow (specific chemical structures or processes) to broader (covering a class of compounds or uses). Broader claims offer greater protection but face higher scrutiny regarding novelty.
Q2: Can CY1123393 be extended beyond 20 years?
A2: Extension is rare for pharmaceutical patents in Cyprus, but supplementary protection certificates (SPCs) can extend patent life in the European Union and similar markets.
Q3: What risks exist if a competing patent overlaps with CY1123393?
A3: Overlapping claims may lead to patent disputes, licensing requirements, or restrictions on commercialization.
Q4: How does patent landscape analysis aid drug development?
A4: It identifies potential patent barriers, licensing opportunities, and areas where freedom to operate exists.
Q5: Does filing a patent in Cyprus protect the drug internationally?
A5: No. Cyprus patent rights are territorial. To protect internationally, the patent family must include filings in other jurisdictions via PCT or direct applications.
References
- European Patent Office. (2020). Patent Search Strategy. Retrieved from https://www.epo.org
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty. Retrieved from https://www.wipo.int
- Cyprus Department of Registrar of Companies and Intellectual Property. (2022). Patent Laws and Guidelines. Retrieved from https://www.mcit.gov.cy
